{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:27:41Z","timestamp":1790537261182,"version":"4.1.0"},"reference-count":55,"publisher":"University of Tokushima Faculty of Medicine","issue":"1.2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2152\/jmi.64.7","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T22:07:25Z","timestamp":1490738845000},"page":"7-13","source":"Crossref","is-referenced-by-count":82,"title":["Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms"],"prefix":"10.2152","volume":"64","author":[{"given":"Koichi","family":"Tsuneyama","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Tsunematsu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Gershwin ME, Ansari AA, Mackay IR, Nakanuma Y, Nishio A, Rowley MJ, Coppel RL: Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 174: 210-25, 2000","DOI":"10.1034\/j.1600-0528.2002.017402.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mackay IR, Gershwin ME: Primary biliary cirrhosis: current knowledge, perspectives, and future directions. Semin Liver Dis 9(2): 149-57, 1989","DOI":"10.1055\/s-2008-1040507"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, De Lellis R, Coppel R, Gershwin ME: Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1\/B7 expression. Hepatology 21(4): 1031-7, 1995","DOI":"10.1002\/hep.1840210422"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y: Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol 186(2): 126-30, 1998","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<126::AID-PATH167>3.0.CO;2-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nakanuma Y, Ohta G: Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76(6): 1326-32, 1979","DOI":"10.1016\/0016-5085(79)90396-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yasoshima M, Nakanuma Y, Tsuneyama K, Van de Water J, Gershwin ME: Immunohistochemical analysis of adhesion molecules in the micro-environment of portal tracts in relation to aberrant expression of PDC-E2 and HLA-DR on the bile ducts in primary biliary cirrhosis. J Pathol 175(3): 319-25, 1995","DOI":"10.1002\/path.1711750310"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chuang YH, Lian ZX, Cheng CM, Lan RY, Yang GX, Moritoki Y, Chiang BL, Ansari AA, Tsuneyama K, Coppel RL, Gershwin ME: Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25(2): 126-32, 2005","DOI":"10.1016\/j.jaut.2005.08.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tsuneyama K, Harada K, Yasoshima M, Hiramatsu K, Mackay CR, Mackay IR, Gershwin ME, Nakanuma Y: Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis. J Pathol 193(1): 102-9, 2001","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH725>3.0.CO;2-P"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsuneyama K, Yososhima M, Hiramatsu K, Harada K, Gershwin ME, Nakanuma Y: A putative role for eotaxin and RANTES in primary biliary cirrhosis: eosinophilic infiltration and damaged bile ducts. Hepatology Research 16(1): 68-77, 1999","DOI":"10.1016\/S1386-6346(99)00042-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K, Kikuchi K, Nakanuma Y, Mackay IR, Gershwin ME, Akashi K: CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 51(2): 567-75, 2010","DOI":"10.1002\/hep.23318"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y: Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts. Hepatology 41(3): 506-16, 2005","DOI":"10.1002\/hep.20582"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sugawara H, Yasoshima M, Katayanagi K, Kono N, Watanabe Y, Harada K, Nakanuma Y: Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma. Histopathology 33(2): 145-53, 1998","DOI":"10.1046\/j.1365-2559.1998.00445.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Harada K, Isse K, Nakanuma Y: Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction. J Clin Pathol 59(2): 184-90, 2006","DOI":"10.1136\/jcp.2004.023507"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Harada K, Nakanuma Y: Molecular mechanisms of cholangiopathy in primary biliary cirrhosis. Med Mol Morphol 39(2): 55-6, 2006","DOI":"10.1007\/s00795-006-0321-z"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y, Chuang YH, Nakamura T, Saito S, Shimoda S, Tanaka A, Bowlus CL, Takano Y, Ansari AA, Coppel RL, Gershwin ME: Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43(4): 729-37, 2006","DOI":"10.1002\/hep.21123"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP, Bowlus CL, Yang GX, Leung PS, Ansari AA, Coppel RL, Gershwin ME: IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 59(5): 1944-53, 2014","DOI":"10.1002\/hep.26979"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tsuneyama K, Yasoshima M, Harada K, Hiramatsu K, Gershwin ME, Nakanuma Y: Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28(3): 620-3, 1998","DOI":"10.1002\/hep.510280303"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. van den Oord JJ, Fevery J, de Groote J, Desmet VJ: Immunohistochemical characterization of inflammatory infiltrates in primary biliary cirrhosis. Liver 4(4): 264-74, 1984","DOI":"10.1111\/j.1600-0676.1984.tb00936.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Krams SM, Van de Water J, Coppel RL, Esquivel C, Roberts J, Ansari A, Gershwin ME: Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology 12(2): 306-13, 1990","DOI":"10.1002\/hep.1840120219"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Nagashima H: Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 6(3): 385-91, 1986","DOI":"10.1002\/hep.1840060309"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Harada K, Ozaki S, Gershwin ME, Nakanuma Y: Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26(6): 1399-405, 1997","DOI":"10.1002\/hep.510260604"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Harada K, Isse K, Kamihira T, Shimoda S, Nakanuma Y: Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis. Hepatology 41(6): 1329-38, 2005","DOI":"10.1002\/hep.20705"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wang D, Zhang H, Liang J, Gu Z, Zhou Q, Fan X, Hou Y, Sun L: CD4+ CD25+ but not CD4+ Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis. Cell Mol Immunol 7(6): 485-90, 2010","DOI":"10.1038\/cmi.2010.40"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Colucci G, Schaffner F, Paronetto F: In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin Immunol Immunopathol 41(1): 35-42, 1986","DOI":"10.1016\/0090-1229(86)90049-8"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hashimoto E, Lindor KD, Homburger HA, Dickson ER, Czaja AJ, Wiesner RH, Ludwig J: Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 68(11): 1049-55, 1993","DOI":"10.1016\/S0025-6196(12)60897-0"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamazaki K, Suzuki K, Nakamura A, Sato S, Lindor KD, Batts KP, Tarara JE, Kephart GM, Kita H, Gleich GJ: Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 30(1): 71-8, 1999","DOI":"10.1002\/hep.510300121"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Terasaki S, Nakanuma Y, Yamazaki M, Unoura M: Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study. Hepatology 17(2): 206-12, 1993","DOI":"10.1002\/hep.1840170208"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Shimoda S, Tsuneyama K, Kikuchi K, Harada K, Nakanuma Y, Nakamura M, Ishibashi H, Hisamoto S, Niiro H, Leung PS, Ansari AA, Gershwin ME, Akashi K: The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis. Clin Exp Immunol 168(3): 279-84, 2012","DOI":"10.1111\/j.1365-2249.2012.04581.x"},{"key":"29","unstructured":"29. Demetris AJ, Sever C, Kakizoe S, Oguma S, Starzl TE, Jaffe R: S100 protein positive dendritic cells in primary biliary cirrhosis and other chronic inflammatory liver diseases. Relevance to pathogenesis? Am J Pathol 134(4): 741-7, 1989"},{"key":"30","unstructured":"30. Rontogianni D, Gerber H, Zimmermann A: Primary biliary cirrhosis (PBC): antigen-presenting cells differ in their distribution in early and late stage PBC and involve the ductal, but not the ductular compartment. Histol Histopathol 9(2): 211-20, 1994"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirshfield GM, Ansari AA, Coppel RT, Gershwin ME, Niu J: Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis. Hepatology 55(5): 1495-506, 2012","DOI":"10.1002\/hep.25511"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takahashi T, Miura T, Nakamura J, Yamada S, Miura T, Yanagi M, Matsuda Y, Usuda H, Emura I, Tsuneyama K, He XS, Gershwin ME: Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis. Hepatology 55(3): 846-55, 2012","DOI":"10.1002\/hep.24757"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, Coppel RL, Worman HJ, Gores GJ, Gershwin ME: Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 52(3): 987-98, 2010","DOI":"10.1002\/hep.23783"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME: Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 49(3): 871-9, 2009","DOI":"10.1002\/hep.22736"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Parikh-Patel A, Gold EB, Worman H, Krivy KE, Gershwin ME: Risk factors for primary biliary cirrhosis in a cohort of patients from the united states. Hepatology 33(1): 16-21, 2001","DOI":"10.1053\/jhep.2001.21165"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Wang JJ, Yang GX, Zhang WC, Lu L, Tsuneyama K, Kronenberg M, Vela JL, Lopez-Hoyos M, He XS, Ridgway WW, Leung PS, Gershwin ME: Escherichia coli infection induces autoimmune cholangitis and anti-mitochondrial antibodies in non-obese diabetic (NOD).B6 (Idd10\/Idd18) mice. Clin Exp Immunol 175(2): 192-201, 2014","DOI":"10.1111\/cei.12224"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ortega-Hernandez OD, Levin NA, Altman A, Shoenfeld Y: Infectious agents in the pathogenesis of primary biliary cirrhosis. Dis Markers 29(6): 277-86, 2010","DOI":"10.1155\/2010\/923928"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Kaplan MM: Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis. Am J Gastroenterol 99(11): 2147-9, 2004","DOI":"10.1111\/j.1572-0241.2004.41121.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, Colvin ME, Lam KS, Coppel RL, Ansari A, Gershwin ME: Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 167(5): 2956-63, 2001","DOI":"10.4049\/jimmunol.167.5.2956"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Long SA, Van de Water J, Gershwin ME: Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 1(1-2): 37-42, 2002","DOI":"10.1016\/S1568-9972(01)00020-9"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, Euen YF, Kurth MJ, Nants MH, Ansari AA, Lam KS, Zeniya M, Matsuura E, Coppel RL, Gershwin ME: Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 174(9): 5874-83, 2005","DOI":"10.4049\/jimmunol.174.9.5874"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WW, Coppel RL, Mackay IR, Gershwin ME: Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 48(2): 531-40, 2008","DOI":"10.1002\/hep.22390"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Taira S, Kaneko D, Kawamura-Konishi Y, Ichiyanagi Y: Application of functionalized nanoparticle for mass spectrometry. J Nanosci Nanotechnol 14(4): 3155-62, 2014","DOI":"10.1166\/jnn.2014.8473"},{"key":"44","unstructured":"44. Taira S, Yamaguchi N, Tatsuta Y, Katano H, Tsuneyama K, Kikuchi K: Liver disease risk of xenobiotics due to percutaneous absorption revealed by nano-PALDI imaging mass spectrometry. International Journal of Recent Scientific Research 7(7): 2016"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ishibashi H, Shimoda S: [Pathogenesis of biliary tract injury in primary biliary cirrhosis]. Nihon Rinsho Meneki Gakkai Kaishi 35(6): 455-62, 2012","DOI":"10.2177\/jsci.35.455"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Shimoda S, Harada K, Niiro H, Shirabe K, Taketomi A, Maehara Y, Tsuneyama K, Nakanuma Y, Leung P, Ansari AA, Gershwin ME, Akashi K: Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis. Hepatology 53(4): 1270-81, 2011","DOI":"10.1002\/hep.24194"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Sasaki M, Miyakoshi M, Sato Y, Nakanuma Y: Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis. J Hepatol 53(2): 318-25, 2010","DOI":"10.1016\/j.jhep.2010.03.008"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Nakanuma Y, Sasaki M, Harada K: Autophagy and senescence in fibrosing cholangiopathies. J Hepatol 62(4): 934-45, 2015","DOI":"10.1016\/j.jhep.2014.11.027"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Salunga TL, Cui ZG, Shimoda S, Zheng HC, Nomoto K, Kondo T, Takano Y, Selmi C, Alpini G, Gershwin ME, Tsuneyama K: Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29(2-3): 78-86, 2007","DOI":"10.1016\/j.jaut.2007.04.002"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Moritoki Y, Lian ZX, Lindor K, Tuscano J, Tsuneyama K, Zhang W, Ueno Y, Dunn R, Kehry M, Coppel RL, Mackay IR, Gershwin ME: B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology 50(6): 1893-903, 2009","DOI":"10.1002\/hep.23238"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Kikuchi K, Lian ZX, Yang GX, Ansari AA, Ikehara S, Kaplan M, Miyakawa H, Coppel RL, Gershwin ME: Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128(2): 304-12, 2005","DOI":"10.1053\/j.gastro.2004.11.005"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Moritoki Y, Lian ZX, Wulff H, Yang GX, Chuang YH, Lan RY, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Gershwin ME: AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 45(2): 314-22, 2007","DOI":"10.1002\/hep.21522"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Kikuchi K, Tsuneyama K, Yamada H, Kajiyama Y, Matsumoto K, Tsunashima H, Yamashita R, Takai A, Negishi M, Hara M, Moritoki Y, Miyakawa H:. Splenic lymph follicles generate immunoglobulin M-producing B cells in primary biliary cirrhosis. Hepatol Res 44(10): E253-E6, 2014","DOI":"10.1111\/hepr.12231"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Tsuda M, Moritoki Y, Lian ZX, Zhang W, Yoshida K, Wakabayashi K, Yang GX, Nakatani T, Vierling J, Lindor K, Gershwin ME, Bowlus CL: Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology 55(2): 512-21, 2012","DOI":"10.1002\/hep.24748"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Tajiri K, Tsuneyama K, Miyazono T, Kawai K, Minemura M, Sugiyama T: A case of primary biliary cirrhosis that progressed rapidly after treatment involving rituximab. Case Rep Gastroenterol 7(1): 195-201, 2013","DOI":"10.1159\/000351173"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/64\/1.2\/64_7\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:08:09Z","timestamp":1568970489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/64\/1.2\/64_7\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":55,"journal-issue":{"issue":"1.2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.64.7","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}